PLOS ONE | April 22, 2010
Read the PublicationShort cycle treatment interruption could reduce toxicity and drug costs and contribute to further expansion of antiretroviral therapy (ART) programs.
Mark Dybul Steven J. Reynolds, Cissy Kityo, Claire W. Hallhan, Geoffrey Kabuye, Diane Atwiine, Frank Mbamanya, Francis Ssali, Robin Dewar, Marybeth Daucher, Richard T. Davey Jr., Anthony S. Fauci, Peter Mugyenyi & Thomas C. Quinn
PLOS ONE | April 22, 2010
Read the PublicationShort cycle treatment interruption could reduce toxicity and drug costs and contribute to further expansion of antiretroviral therapy (ART) programs.
Op-Ed
September 29, 2023
Op-Ed
September 27, 2023
Op-Ed
September 22, 2023